Literature DB >> 1325216

Value of cytometric analysis for distinction of intraductal carcinoma of the breast.

E R Fisher1, R Siderits.   

Abstract

The DNA nuclear content of 83 'pure' intraductal cancers (DCIS), 30 DCIS with an invasive component, 7 intraductal papillomas, 26 atypical hyperplasias, and 5 'hobnail' lesions was determined with a Cell Analysis Systems Image Analyzer (CAS 200). No consistent quantitative alteration of DNA or nuclear grade assessed by routine microscopy was observed for any ductal change diagnostic of DCIS. Fifty-eight percent of all DCIS were considered to be aneuploid, whereas all papillomas and atypical hyperplasias were diploid with normoproliferative S-phase and good nuclear grade. Use of ploidy, S phase, or nuclear grade for the distinction of DCIS and papillomas and atypical hyperplasia is limited, since their estimates would be comparable in 42%, 46%, and 40% of instances respectively. Poor nuclear grade was significantly more frequent in solid than cribriform types of DCIS. There were no significant differences in any parameters in DCIS with and without comedo necrosis. This represents further evidence against recognition of a unique comedo form of DCIS. DNA histograms of nuclei comprising the 'hobnail' lesions were aneuploid. Despite this their biologic nature is uncertain. No consistent differences in DNA content were noted between DCIS with and without an invasive component. This obfuscates insight into the role of DCIS in the development of invasive cancer of the breast.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325216     DOI: 10.1007/bf01974999

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  8 in total

1.  Importance of cellular DNA content in pre-malignant breast disease and pre-invasive carcinoma of the female breast.

Authors:  R Carpenter; N Gibbs; J Matthews; T Cooke
Journal:  Br J Surg       Date:  1987-10       Impact factor: 6.939

2.  Conservative management of intraductal carcinoma (DCIS) of the breast. Collaborating NSABP investigators.

Authors:  E R Fisher; R Leeming; S Anderson; C Redmond; B Fisher
Journal:  J Surg Oncol       Date:  1991-07       Impact factor: 3.454

3.  The clinical significance of pre-invasive breast carcinoma.

Authors:  P P Rosen; D W Braun; D E Kinne
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

4.  Cell kinetics of histologic variants of in situ breast carcinoma.

Authors:  J S Meyer
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

5.  Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS).

Authors:  E R Fisher; R Sass; B Fisher; L Wickerham; S M Paik
Journal:  Cancer       Date:  1986-01-15       Impact factor: 6.860

6.  A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast.

Authors:  F A Tavassoli; H J Norris
Journal:  Cancer       Date:  1990-02-01       Impact factor: 6.860

7.  Intraductal carcinoma of the breast: follow-up after biopsy only.

Authors:  D L Page; W D Dupont; L W Rogers; M Landenberger
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

8.  A comparative morphometric and cytophotometric study of intraductal hyperplasia and intraductal carcinoma of the breast.

Authors:  H J Norris; G F Bahr; U V Mikel
Journal:  Anal Quant Cytol Histol       Date:  1988-02       Impact factor: 0.302

  8 in total
  1 in total

Review 1.  The need for epidemiologic studies of in-situ carcinoma of the breast.

Authors:  R Millikan; L Dressler; J Geradts; M Graham
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.